Jeroen Depreeuw Selected Research

Trastuzumab (Herceptin)

10/2016

Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeroen Depreeuw Research Topics

Disease

11	Neoplasms (Cancer) 10/2018 - 03/2015
7	Endometrial Neoplasms (Endometrial Cancer) 12/2017 - 01/2015
2	Endometrioid Carcinoma 10/2016 - 10/2015
2	Microsatellite Instability 10/2016 - 10/2015
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Carcinogenesis 01/2018
1	Ischemia 01/2018
1	Genomic Instability 01/2018
1	Carcinosarcoma 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017
1	Adenocarcinoma 10/2016

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2015
2	AZD 6244IBA 10/2015 - 07/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015 - 07/2015
2	dactolisibIBA 10/2015 - 07/2015
1	Bevacizumab (Avastin)FDA Link 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	EnzymesIBA 01/2018
1	Exonucleases (3' 5' Exonuclease)IBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2017
1	IGF-I-IGFBP-3 complex FDA Link 10/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2016
1	Trastuzumab (Herceptin)FDA Link 10/2016
1	human ERBB2 proteinIBA 10/2016
1	Estradiol (Delestrogen)FDA LinkGeneric 02/2016
1	Keratins (Keratin)IBA 10/2015
1	Estrogens (Estrogen)FDA Link 10/2015
1	VimentinIBA 10/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Hepatocyte Nuclear Factor 1IBA 03/2015

Therapy/Procedure

5	Therapeutics 10/2018 - 01/2015
2	Drug Therapy (Chemotherapy) 10/2018 - 10/2015
1	Ligation 12/2017